Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mackenzie L Cottrell

Showing results (41-50 of 74) with videos related to

Pageof 8
Sort By:
Biorxiv : the Preprint Server for Biology|September 4, 2023
CD4 T cell Responses in the CNS during SIV infectionSonny R Elizaldi, Anil Verma, Zhong-Min Ma, et al.
The Journal of Antimicrobial Chemotherapy|April 4, 2017
Single-dose pharmacokinetics of tenofovir alafenamide and its active metabolite in the mucosal tissuesMackenzie L Cottrell, Katy L Garrett, Heather M A Prince, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 5, 2023
Long-acting injectable multipurpose prevention technology for prevention of HIV and unplanned pregnancyIsabella C Young, Aryani Pallerla, Mackenzie L Cottrell, et al.
Contraception: X|December 28, 2020
Effect of efavirenz on levonorgestrel concentrations among Malawian levonorgestrel implant users for up to 30 months of concomitant use: a subanalysis of a randomized clinical trialJennifer H Tang, Nicole L Davis, Amanda H Corbett, et al.
Clinical Pharmacology and Therapeutics|January 9, 2023
A Novel Algorithm to Improve PrEP Adherence Monitoring Using Dried Blood SpotsAaron S Devanathan, Julie B Dumond, Daijha J C Anderson, et al.
Pharmaceutics|May 27, 2026
Harnessing Pharmacokinetic Modeling to Develop a Long-Acting Subcutaneous HIV Treatment Platform for Young ChildrenDaniel Oliveira, Daniela Cruz, Leanna P K Levin, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 14, 2020
Antiretroviral Therapy Concentrations Differ in Gut vs. Lymph Node Tissues and Are Associated With HIV Viral Transcription by a Novel RT-ddPCR AssaySulggi A Lee, Sushama Telwatte, Hiroyu Hatano, et al.
AIDS (London, England)|October 25, 2023
Vaginal microbiome, antiretroviral concentrations, and HIV genital shedding in the setting of hormonal contraception initiation in MalawiAlyssa M Lantz, Mackenzie L Cottrell, Amanda H Corbett, et al.
The Journal of Infectious Diseases|October 31, 2025
Cabotegravir and Rilpivirine concentrations and HIV-1 RNA suppression in genital fluids and rectum in people with HIV on long-acting intramuscular Cabotegravir plus Rilpivirine antiretroviral therapyAnaluz Fernández, Sofia Scévola, Jordi Niubó, et al.
Iscience|June 6, 2022
The <i>ex vivo</i> pharmacology of HIV-1 antiretrovirals differs between macaques and humansCarolina Herrera, Mackenzie L Cottrell, John Prybylski, et al.
Pageof 8

Showing results (41-50 of 74) with videos related to

Sort By:
Pageof 8
Biorxiv : the Preprint Server for Biology|September 4, 2023
CD4 T cell Responses in the CNS during SIV infectionSonny R Elizaldi, Anil Verma, Zhong-Min Ma, et al.
The Journal of Antimicrobial Chemotherapy|April 4, 2017
Single-dose pharmacokinetics of tenofovir alafenamide and its active metabolite in the mucosal tissuesMackenzie L Cottrell, Katy L Garrett, Heather M A Prince, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 5, 2023
Long-acting injectable multipurpose prevention technology for prevention of HIV and unplanned pregnancyIsabella C Young, Aryani Pallerla, Mackenzie L Cottrell, et al.
Contraception: X|December 28, 2020
Effect of efavirenz on levonorgestrel concentrations among Malawian levonorgestrel implant users for up to 30 months of concomitant use: a subanalysis of a randomized clinical trialJennifer H Tang, Nicole L Davis, Amanda H Corbett, et al.
Clinical Pharmacology and Therapeutics|January 9, 2023
A Novel Algorithm to Improve PrEP Adherence Monitoring Using Dried Blood SpotsAaron S Devanathan, Julie B Dumond, Daijha J C Anderson, et al.
Pharmaceutics|May 27, 2026
Harnessing Pharmacokinetic Modeling to Develop a Long-Acting Subcutaneous HIV Treatment Platform for Young ChildrenDaniel Oliveira, Daniela Cruz, Leanna P K Levin, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 14, 2020
Antiretroviral Therapy Concentrations Differ in Gut vs. Lymph Node Tissues and Are Associated With HIV Viral Transcription by a Novel RT-ddPCR AssaySulggi A Lee, Sushama Telwatte, Hiroyu Hatano, et al.
AIDS (London, England)|October 25, 2023
Vaginal microbiome, antiretroviral concentrations, and HIV genital shedding in the setting of hormonal contraception initiation in MalawiAlyssa M Lantz, Mackenzie L Cottrell, Amanda H Corbett, et al.
The Journal of Infectious Diseases|October 31, 2025
Cabotegravir and Rilpivirine concentrations and HIV-1 RNA suppression in genital fluids and rectum in people with HIV on long-acting intramuscular Cabotegravir plus Rilpivirine antiretroviral therapyAnaluz Fernández, Sofia Scévola, Jordi Niubó, et al.
Iscience|June 6, 2022
The <i>ex vivo</i> pharmacology of HIV-1 antiretrovirals differs between macaques and humansCarolina Herrera, Mackenzie L Cottrell, John Prybylski, et al.
Pageof 8